Full-Time

Quality Assurance Archivist

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

501-1,000 employees

Develops RNAi-based therapies for diseases

Compensation Overview

$60k - $75k/yr

Mid

Fitchburg, WI, USA

Category
QA & Testing
Quality Assurance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • High School diploma
  • At least three years of experience working in an FDA regulated environment in an archiving or document management role.
  • Strong understanding of pharmaceutical regulations, intellectual property, and the importance of maintaining corporate history for regulatory and business purposes, including Good Laboratory Practices (GLP), Good Manufacturing Practices (GMP), and/or Good Documentation Practices (GDP) regulations.
  • Competent knowledge of and ability to use Microsoft Word and Excel.
  • Proficiency with archival software and digital records management systems (e.g., Veeva Vault, OpenText, or other industry-specific tools). Familiarity with metadata standards, digital preservation techniques, and document scanning technologies.
Responsibilities
  • Oversee the archival collection of physical and digital documents, including historical records, research data, regulatory documents, product development files, marketing materials, and other corporate assets. Ensure documents are organized, cataloged, and indexed for easy retrieval.
  • Implement and maintain a digital archival system for electronic records, ensuring compatibility with current technologies and the company’s IT infrastructure. Convert physical records to digital formats where necessary and ensure proper metadata tagging.
  • Ensure that all records comply with regulatory requirements, including those set by health authorities such as the FDA, EMA, and other regulatory bodies. Assist in the management of records retention schedules and disposal protocols to meet legal and business requirements.
  • Develop strategies for the long-term preservation of physical and digital records. Maintain conditions for the safeguarding of valuable documents, including proper storage environments, and manage the restoration and conservation of damaged materials.
  • Serve as the primary point of contact for internal and external requests for archived materials. Provide efficient and timely access to historical records for various departments, including R&D, legal, marketing, and senior management.
  • Conduct research using the archived records to support business initiatives, corporate history projects, or external inquiries. Prepare reports, presentations, and summaries based on historical data as required by leadership or external stakeholders.
  • Provide training and guidance to staff on best practices for records management and archiving. Promote awareness of archival resources and procedures across the company.
  • Regularly assess and improve the archival process, tools, and systems. Stay updated with industry best practices, emerging technologies, and legal changes related to record management.
  • Additional duties as assigned.
Desired Qualifications
  • Certification in Archives Management (e.g., Certified Archivist) or Records Management (e.g., Certified Records Manager).
  • Experience with pharmaceutical regulatory filings and the lifecycle of drug development documentation.
  • Familiarity with cloud-based archival and content management solutions.
  • Ability to work with large volumes of information and maintain accurate, comprehensive, and organized records.
  • Ability to multi-task and prioritize work tasks with minimal supervision.
  • Excellent written and verbal communication skills, with the ability to interact with a wide range of internal stakeholders and external parties.
  • Strong analytical and problem-solving skills, with the ability to adapt to changing business needs and regulatory requirements.
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing the genes responsible for them. The company uses RNA interference (RNAi), a natural process that reduces the expression of specific genes, to achieve effective treatment outcomes. This method allows for significant and lasting reductions in the activity of harmful genes, which can help manage or potentially reverse diseases like cystic fibrosis and hepatitis B. Arrowhead stands out from its competitors by focusing specifically on RNAi-based therapies and leveraging a wide range of RNA chemistries and delivery methods. The company aims to meet unmet medical needs by providing new treatment options for genetic disorders, generating revenue through partnerships, licensing agreements, and future sales of approved therapies.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's collaboration with Sarepta includes a $500M upfront payment for RNA drug development.
  • Positive Phase 2 data for plozasiran boosts Arrowhead's credibility in treating hypertriglyceridemia.
  • Strategic financing with Sixth Street provides capital to advance Arrowhead's research pipeline.

What critics are saying

  • Increased competition from companies like Alnylam may impact Arrowhead's market share.
  • Potential regulatory scrutiny could delay Arrowhead's clinical trials for RNAi therapies.
  • Reliance on strategic financing may lead to increased debt obligations for Arrowhead.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi to target and silence disease-causing genes effectively.
  • The company has a broad portfolio of RNA chemistries for diverse therapeutic applications.
  • Arrowhead's strategic partnerships enhance its capabilities in developing innovative RNAi therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

Company News

BioSpace
Apr 15th, 2025
Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer

Mr. Apel joins the company from Walgreens Boots Alliance, where he served as Global Head of Financial Planning and Analysis from 2019 through 2024.

PharmaData
Mar 1st, 2025
Arrowhead Pharmaceuticals Launches FCS Patient Resources on Rare Disease Day

Arrowhead Pharmaceuticals launches FCS patient resources on Rare Disease Day.

Business Wire
Feb 28th, 2025
Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)

New Patient Resource Hub: Arrowhead expands its We'll Get There Soon campaign with the launch of a dedicated patient website, providing education, tools, and support for those living with FCS and extremely high triglycerides

World Pharmaceuticals
Nov 29th, 2024
Dev4All and Pharmaseed enter commercial partnership for preclinical R&D

Recently, Arrowhead Pharmaceuticals and Sarepta Therapeutics signed a global licensing and collaboration agreement to develop clinical and preclinical programmes.

BioSpace
Nov 26th, 2024
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs

Sarepta Therapeutics is putting massive biobucks on the line to work on RNA drugs with Arrowhead, paying out $500 million upfront to find new treatments for rare genetic diseases of the muscle, central nervous system and lung.